1. Esculentoside A ameliorates BSCB destruction in SCI rat by attenuating the TLR4 pathway in vascular endothelial cells.
- Author
-
Zhu, Guoqing, Song, Xue, Sun, Yang, Xu, Yibo, Xiao, Linyu, Wang, Zhiyuan, Sun, Yijie, Zhang, Liubaoju, Zhang, Xiaofeng, Geng, Zhijun, Qi, Qi, Wang, Yueyue, Wang, Lian, Li, Jing, Zuo, Lugen, and Hu, Jianguo
- Subjects
- *
VASCULAR endothelial cells , *TOLL-like receptors , *INFLAMMATORY mediators , *SPINAL cord injuries , *MOLECULAR docking , *TIGHT junctions - Abstract
Overexpressed MMP-9 in vascular endothelial cells is involved in blood spinal cord barrier (BSCB) dysfunction in spinal cord injury (SCI). Esculentoside A (EsA) has anti-inflammatory and cell protective effects. This study aimed to evaluate its effects on neuromotor function in SCI rats, as well as the potential mechanisms. The therapeutic effect of EsA in SCI rats was investigated using Basso-Beattie-Bresnahan (BBB) scores, a grid walk test and histological analyses. To assess the protective role of EsA in the BSCB and in oxygen glucose deprivation/reoxygenation (OGD/R)-induced hBMECs, the BSCB function, tight junctions (TJ) protein (ZO-1 and claudin-5) expression, structure of the BSCB and Matrix metalloproteinase-9 (MMP-9) expression were observed via Evans blue (EB) detection, immunofluorescence analyses and western blotting. Molecular docking simulations and additional experiments were performed to explore the potential mechanisms by which EsA maintains the function of the BSCB in vivo and in vitro. EsA treatment improved BBB scores, reduced cavity formation and the loss of neuronal cells, demonstrating an improvement in motor function in SCI rats. In vivo experiments showed that EsA decreased the infiltration of blood cells and inflammatory mediators (IL-1β, IL-6 and TNF-α) and protected the structure of TJs in the rat spinal cord and in OGD/R-induced hBMECs. EsA inhibited the activation of Toll-like receptor 4 (TLR4) signalling, which may be related to the protective effect of EsA against MMP-9-induced BSCB damage. EsA downregulated MMP-9 expression in vascular endothelial cells, protected BSCB function in SCI rats and attenuated TLR4 signalling and thus provide new options for the treatment of SCI. • Esculentoside A treatment promoted the recovery of motor function in rats after SCI. • Esculentoside A treatment decreased the cytokine levels caused by increased BSCB permeability. • Esculentoside A protects the function of the BSCB by attenuating the expression of MMP-9 induced by TLR4 signalling. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF